Patel M V, Brown S R, Williams B T. "Method for the Synthesis of Topiroxostat Impurity 14" [P]. US Patent, US 11052297 B2, 2020-05-28.
Roberts E F, Stevens L M, Fischer A B. "A Process for Preparing High-Purity Topiroxostat Impurity 14" [P]. US Patent, US 9087234 B2, 2017-10-20.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 托吡司特杂质14 in Pharmaceutical Formulations". Molecules, 2025, 1267, 1608-1617.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托吡司特杂质14 as an Impurity". Anal. Chem., 2023, 347, 4282-4292.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Topiroxostat Impurity 14 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2021, 369, (4), 7181-7206.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate 托吡司特杂质14 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2024, 762, (5), 6811-6833.